Inside Precision Medicine January 21, 2025
A fast test to determine if an infection is viral or bacterial or whether a patient may progress to a more severe condition such as sepsis, has been approved by the FDA.
The test was developed by California-based Inflammatix. Known as TriVerity, it is a benchtop machine that uses a cartridge-based system to test patient samples.
It is able to measure the expression of 29 genes that regulate a person’s response to infection and assess if they have a high likelihood of having a bacterial or viral infection within around 30 minutes.
The test is also able to indicate how sick a patient is likely to become over the week following the test. For example, if they have a condition...
Today's Sponsors
Today's Sponsor